{"id":15954,"date":"2021-04-13T09:04:23","date_gmt":"2021-04-13T09:04:23","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it2\/?page_id=15954"},"modified":"2025-12-22T11:21:01","modified_gmt":"2025-12-22T11:21:01","slug":"miguel-barrero","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\/geschaeftsfuehrung\/miguel-barrero","title":{"rendered":"MIGUEL BARRERO"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/mbarrero\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Miguel Barrero<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Miguel Barrero Dur\u00e1n ist Head of Business Development & Innovation und kam 2015 zu Neuraxpharm, wo er die Abteilungen Business Development & Licensing, Alliance Management und seit kurzem auch Pipeline aufbaute und weiterentwickelte. Miguel leitet au\u00dferdem die Abteilung Intellectual Property.<\/p>

Er verf\u00fcgt \u00fcber mehr als 22 Jahre Erfahrung in der pharmazeutischen Industrie in verschiedenen Funktionen und Unternehmen. Seine berufliche Laufbahn begann er im Jahr 2000 bei Almirall, gefolgt von Merck Serono im Jahr 2005 und Esteve im Jahr 2008, wo er in leitenden Funktionen in der pharmazeutischen Entwicklung t\u00e4tig war und einen umfassenden technischen und wissenschaftlichen Hintergrund erwarb.<\/p>

Vor seiner Zeit bei Neuraxpharm hatte er eine Reihe von leitenden Positionen im Bereich Business Development inne, darunter Auslizenzierungen bei Invent Farma und Hetero Europe sowie Einlizenzierungen und Gesch\u00e4ftsentwicklung durch strategische Partnerschaften und Unternehmensentwicklungen.<\/p>

Er hat einen Bachelor-Abschluss in Pharmazie von der Universit\u00e4t Barcelona und einen MBA von der globalen Hochschule ESADE.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n ist Head of Business Development & Innovation und kam 2015 zu Neuraxpharm, wo er die Abteilungen Business Development & Licensing, Alliance Management und seit kurzem auch Pipeline aufbaute und weiterentwickelte. Miguel leitet au\u00dferdem die Abteilung Intellectual Property. Er verf\u00fcgt \u00fcber mehr als 22 Jahre Erfahrung in der pharmazeutischen […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-15954","page","type-page","status-publish","hentry"],"yoast_head":"\nMIGUEL BARRERO - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL BARRERO\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n ist Head of Business Development & Innovation und kam 2015 zu Neuraxpharm, wo er die Abteilungen Business Development & Licensing, Alliance Management und seit kurzem auch Pipeline aufbaute und weiterentwickelte. Miguel leitet au\u00dferdem die Abteilung Intellectual Property. Er verf\u00fcgt \u00fcber mehr als 22 Jahre Erfahrung in der pharmazeutischen […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-22T11:21:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/m-barrero.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\/geschaeftsfuehrung\/miguel-barrero\",\"url\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella\",\"name\":\"MIGUEL BARRERO - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/m-barrero.jpg\",\"datePublished\":\"2021-04-13T09:04:23+00:00\",\"dateModified\":\"2025-12-22T11:21:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#breadcrumb\"},\"inLanguage\":\"de-CH\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-CH\",\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092609\/m-barrero.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092609\/m-barrero.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00dcber uns\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gesch\u00e4ftsf\u00fchrung\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\/geschaeftsfuehrung\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MIGUEL BARRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-de\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-CH\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MIGUEL BARRERO - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella","og_locale":"de_DE","og_type":"article","og_title":"MIGUEL BARRERO","og_description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n ist Head of Business Development & Innovation und kam 2015 zu Neuraxpharm, wo er die Abteilungen Business Development & Licensing, Alliance Management und seit kurzem auch Pipeline aufbaute und weiterentwickelte. Miguel leitet au\u00dferdem die Abteilung Intellectual Property. Er verf\u00fcgt \u00fcber mehr als 22 Jahre Erfahrung in der pharmazeutischen […]","og_url":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2025-12-22T11:21:01+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/m-barrero.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\/geschaeftsfuehrung\/miguel-barrero","url":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella","name":"MIGUEL BARRERO - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/m-barrero.jpg","datePublished":"2021-04-13T09:04:23+00:00","dateModified":"2025-12-22T11:21:01+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#breadcrumb"},"inLanguage":"de-CH","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella"]}]},{"@type":"ImageObject","inLanguage":"de-CH","@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092609\/m-barrero.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092609\/m-barrero.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/massimo-cappella#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00dcber uns","item":"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns"},{"@type":"ListItem","position":2,"name":"Gesch\u00e4ftsf\u00fchrung","item":"https:\/\/www.neuraxpharm.com\/ch-de\/uber-uns\/geschaeftsfuehrung"},{"@type":"ListItem","position":3,"name":"MIGUEL BARRERO"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-de\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-de\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-CH"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/comments?post=15954"}],"version-history":[{"count":21,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15954\/revisions"}],"predecessor-version":[{"id":25364,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15954\/revisions\/25364"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/media?parent=15954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}